Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
low titers/didn't have a response; This non-serious case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a 48-year-old female patient who received MMR (Priorix) for prophylaxis. Concomitant products included aciclovir sodium (Acyclovir). On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced therapy non-responder (Verbatim: low titers/didn't have a response). The outcome of the therapy non-responder was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-MAR-2025 Reporter stated that a patient who was currently on Acyclovir had gotten a dose of Priorix back in 2020 no exact date shared, and did not have a response, reporter mentioned that this patient had a titer test and showed low titers.
ACYCLOVIR